(Q58065024)
Statements
A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in Thailand (English)
K Ruxrungtham
S Suwanagool
J A Tavel
M Chuenyam
E Kroon
S Ubolyam
S Buranapraditkun
W Techasathit
Y Li
R T Davey
L Fosdick
C Kunanusont
P Phanuphak
Vanguard Study Group